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Abstract
Accumulation of somatic changes, due to environmental and endogenous lesions, in the
human genome is associated with aging and cancer. Understanding the impacts of these
processes on mutagenesis is fundamental to understanding the etiology, and improving the
prognosis and prevention of cancers and other genetic diseases. Previous methods relying
on either the generation of induced pluripotent stem cells, or sequencing of single-cell
genomes were inherently error-prone and did not allow independent validation of the muta-
tions. In the current study we eliminated these potential sources of error by high coverage
genome sequencing of single-cell derived clonal fibroblast lineages, obtained after minimal
propagation in culture, prepared from skin biopsies of two healthy adult humans. We report
here accurate measurement of genome-wide magnitude and spectra of mutations accrued
in skin fibroblasts of healthy adult humans. We found that every cell contains at least one
chromosomal rearrangement and 600–13,000 base substitutions. The spectra and correla-
tion of base substitutions with epigenomic features resemble many cancers. Moreover,
because biopsies were taken from body parts differing by sun exposure, we can delineate
the precise contributions of environmental and endogenous factors to the accrual of genetic
changes within the same individual. We show here that UV-induced and endogenous DNA
damage can have a comparable impact on the somatic mutation loads in skin fibroblasts.
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Author Summary
Somatic genomes are constantly accumulating changes caused by endogenous lesions,
errors in DNA replication and repair, as well as environmental insults. Despite the impor-
tance of somatic genome instability in aging and age-related pathologies, including can-
cers, accurate measurements of mutation loads in healthy cells is still missing. In this
study, we developed an experimental approach to accurately determine the somatic
genome changes accrued in cell lineages over the lifetime of healthy humans. We show
that the amounts and types of mutations in skin cells resemble many cancers, thus indicat-
ing that the mechanisms that lead to carcinogenesis are also functional in healthy cells.
Moreover, sun-exposed skin cells have a higher mutation load attributable to ultraviolet
radiation (UV) unlike cells from hips that were protected by clothing. Our work provides
precise measurements of the mutation loads in single cells in human skin. Furthermore
our data allowed defining the mutagenic impacts of environmental and endogenous pro-
cesses within the same individual and led to conclusion that these processes have a compa-
rable impact on the somatic mutation load.
Introduction
EndogenousDNA lesions and inaccuracies in replication and repair, as well as environmental
DNA damage result in a buildup of mutations throughout the human genome over the lifetime
of the individual. Studies with transgenicmice have demonstrated that genome instability
increases with age and in agreement with tissue-specificproliferation capacities [1, 2]. Also,
somatic mutation frequency in human cancers has been shown to increase with the age of the
patients at the time of tumor excision [3–5] and various studies using reporter systems in human
cells have demonstrated that the increase in mutations with age is dependent on the tissue-type
being tested (reviewed in [6]). Central to all models of somatic mutation accumulation with age
is the hypothesis that mutation loads are a product of endogenous and environmental mutational
processes. However, the impact of these factors on carcinogenesis has only been assessed indi-
rectly. A comparison of mutation data in various types of tumors with the levels of cell prolifera-
tion in the affected tissues led to the conclusion that DNA replication-associatedmutagenesis in
non-cancerous stem cells is the foremost contributor to carcinogenesis [7]. Alternatively, taking
into account epidemiological studies and mutation signatures associatedwith knownmutagens,
the primary risk factor for cancers has been proposed to be environmental [8].
Buildup of somatic genetic changes during human lifetime was proposed to result in
somatic mosaicism, and the existence of such mosaicism, had been recently demonstrated by
several groups (reviewed in [9, 10]). This led to the next set of questions about defining spec-
trum and measuring rates of genome changes resulting in somatic mosaicism. In vivo, muta-
tion rates in human somatic cells were previously measured in single-gene reporters or by
detectingmutations in a small fraction of the genome (reviewed in [10, 11]). Such estimates are
unsuitable for genome-wide extrapolation because they vary considerably (from 10−9 to nearly
10−7 per nt/cell division [12, 13]) and because rates of changes differ across the genome [14]. In
a recent study, mutations characteristic of ultraviolet (UV) radiation in human somatic tissues,
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normally exposed to UV over lifetime, were analyzed by conducting ultra-deep sequencing of
74 genes in DNA extracted from eyelid biopsies as well as whole genome sequencing of DNA
obtained from a mixture of cells within one biopsy [15]. This approach is well suited to detect
somatic changes accumulated in a significant fraction of cells either by chance or due to selec-
tion. However, when a bulk of cells directly obtained from a biopsy are sequenced, the detec-
tion and validation of somatic mutations unique to a single cell or present in a very small
fraction of cells in a given tissue, is extremely challenging and precludes precise determination
of the scale of mutagenesis over an individual’s life time.While single-cell sequencing analyses
have facilitated the estimation of genome-widemutation load in individual non-cancerous
human cells, such assays have unavoidable amplification errors which can significantly obscure
mutation calling and the method does not allow independent validation of mutation calls [16].
Sequencing of induced pluripotent stem cell lines could circumvent this difficulty, however,
generation of such lines is inherently mutagenic [17]. As such, precise determination of muta-
tion loads in human somatic cells is still missing.
We report here accurate estimates of various types of somatic genome changes accumulated in
somatic cell lineages, across the entire genome.Moreover, our experimental design enabled us to
compare mutagenesis contributed by endogenous and environmental factors within the same indi-
viduals, leading to the conclusion that the mutagenic impacts of these processes are comparable.
Results
Experimental design
Normal fibroblasts reside in the connective tissues and are responsible for generating extra cel-
lular matrix. Oncogenic transformation of cells within the connective tissue leads to fibrosarco-
mas. Studies in mice have demonstrated that histologically normal epithelial cells can be
induced to form tumors by generation of oncogenic mutations in the stromal fibroblasts [18,
19]. Fibroblasts isolated from the stroma of various human cancers including melanoma also
have higher proliferation rates and capacity. Thus, emerging evidence has demonstrated that
besides a supportive role in cancer initiation and progression, cancer-associated fibroblasts can
also be drivers of carcinogenesis [20], which makes it pertinent to study the acquisition of
somatic mutations in these cells in healthy individuals over time. Importantly, skin fibroblasts
are readily accessible from small punch biopsies and possess proliferative potential enabling
clones derived from single cells in primary culture to grow to sufficient cell density for DNA
library preparation and next-generation DNA sequencing. This method allows for accurate
estimation of the mutation loads in the progenitor cell that gave rise to the clonal human cell
lines, and permits systematic verification of the somatic changes.
We sequenced the genomes of 10 clonal fibroblast cell lineages, generated by limited propa-
gation of cells obtained from skin punch biopsies. The biopsies were obtained from the left and
right forearms and hips of two healthy donors (ages 58 and 62), where significant fraction of
cells retained the capability to grow in culture (Fig 1 and S1 Fig). For Donor 1, we obtained two
additional biopsies adjacent to the initial positions at the right hip and left forearm (Fig 1). We
reasoned that the forearms would have had greater exposure to sunlight than hips, which
would allow estimation of the impact of this environmental factor on the accumulation of
genome changes as compared with unexposed sites within the same donor. Studies on recon-
structed skin have determined that unlike UVB rays that are only capable of penetrating the
epidermis, UVA rays can reach the dermal layer [21]. Also, fibroblasts in sunlight-exposed
skin are subject to UVA-induced damage producing wrinkles, solar elastosis [22] and likely
several forms of mutagenic DNA damage. Thus, we expect to detect an excess of UV-induced
mutations in the forearms of both donors.
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Single fibroblasts were isolated from each biopsy and expanded clonally in culture for 5–6
additional passages (4–6 weeks) to obtain approximately 106 cells.Whole genome sequencing
was performed to get 40-60X coverage for each sample. Whole bloodwas also obtained from
each donor and DNA was extracted and sequenced to a similar depth. Over 91% of the genomes
of each clone had a minimum coverage of 10 reads (S1 Table). All changes present in the clones
and absent from the corresponding sequenced bloodDNA, which is made up of a heterogeneous
cell population, and whosemutation calls and other genome changes likely represent the germ-
line genotype of a donor, were deemed somatic in origin and unique to the fibroblast clones.
Detecting retrotransposition events in the clones
We searched for somatic retrotransposition events in the clones similar to those shown for can-
cer genomes of epithelial origins [23, 24]. However, in the 10 genomes from normal skin fibro-
blasts, we detected only two LI insertion candidates, one of which showed the signatures of a
bona fide retrotransposition by target primed reverse transcription—14 bp target site duplica-
tion and poly-A tail. But, the clonality of the events was estimated to be 2–12% (S2 Fig and S2
Table), suggesting that they were acquired during the clonal expansion and were not present in
the progenitor cell that gave rise to the clone. Our analysis supports the view that somatic retro-
transposition is inhibited to a greater extent in fibroblasts than in germ cells [25].
Genome-wide identification of somatic structural changes
Large scale somatic copy number variations (CNVs) have been previously implicated in neuro-
logical diseases, autoimmune diseases, heart diseases and cancers [26]. Through analysis of
Fig 1. Schematic for isolation and sequencing of single-cell fibroblast clonal lineages. Example of Donor 1 is shown. Boxed insert illustrates
the design of the clone IDs. Biopsy number is indicated if adjacent biopsies were taken from the same site.
doi:10.1371/journal.pgen.1006385.g001
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sequencing read depth by VarScan2 and correction for GC content [27, 28], we detected a total
of 57 clonal somatic deletions in the genomes of skin fibroblasts resulting in a ploidy of 1n, and
13 amplification events with a ploidy of 3n. Each clone was found to contain more than one
(ranging 2 to 22) somatic copy number variation (CNV).Most CNVs were focal in nature,
however, we found 5 CNVs that span over the entire chromosomal arm in 3 out of the 10
clones (S3 Table).
We also detected 57 somatic structural changes with formation of novel junctions based on
analysis of split and discordant paired-end reads by DELLY [29]. Only calls with>30% of the
reads supporting the novel junctions were deemed clonal. This allows us to eliminate sub-
clonal structural variations that may have occurred in the clones during propagation in culture.
Many rearrangements were further supported by the independently called CNVs mentioned
above, and by the presence of loss of heterozygosity (LOH) tracts in the regions with heterozy-
gous deletions (Fig 2A, S3 Fig, S4 Fig, S3 Table, S4 Table and S5 Table). LOH events are called
by VarScan2 as somatic, when a base pair different from the reference genome GRCh37, het-
erozygous in bloodDNA, turns homozygous in the clone from the same donor. We validated
34 somatic structural changes by PCR and Sanger sequencing the breakpoints (S5 Fig and S4
Table).
Interestingly, several structural rearrangements were present in the vicinity of known fragile
sites (data taken from [30]). For example, the chr20 left arm has a 15 Mb terminal deletion,
and the 21 Mb terminal region of the right arm of chr19 is amplified to 3 copies. We also
detected a translocation between chromosome 20 and chromosome 19 in the regions with
copy number changes. We posit that such a rearrangement might occur from double strand
break in chr20 followed by break-induced replication over the right arm of chr19 (Fig 2B and
S4 Table). The region comprising the breakpoint in chr20 is a known rare fragile site and rear-
rangements involving this region have been implicated in the pathology of Alagille syndrome
and in colorectal cancers [31–33]. Also, 3 of the 4 clones from donor2 and 1 clone (left fore-
arm) from donor1 carry different heterozygous deletions in the NRXN1 locus of chr7 (S4
Table). This region is also a known hotspot for structural variations and deletions of this locus
Fig 2. Structural changes detected in skin fibroblast clones D1-L-F1 and D2-L-F. (A) All genome changes detected in D1-L-F1 and D2-L-F clones.
The tracks numbered from innermost are as follows: 1—structural changes. Green = deletions, black = duplications, blue = inversions and
red = translocations. 2—deletions as detected by read-depth analyses. 3—amplifications as detected by read-depth analyses. 4—LOH events. 5—
somatic SNVs, black dots are heterozygous SNVs and red dots are homozygous SNVs. (B) Schematic describing the chr19, chr20 translocation in
D1-L-F1. Black rectangles depict region wherein translocation event was detected with a concomitant change in copy number.
doi:10.1371/journal.pgen.1006385.g002
Somatic Mutagenesis Over Human Lifetime
PLOS Genetics | DOI:10.1371/journal.pgen.1006385 October 27, 2016 5 / 25
have been implicated in the autism spectrumdisorders [34]. This locus is enriched in small
inverted repeats that have been shown to lead to replication fork stalling and gross chromo-
somal rearrangements [35–37]. These rearrangements implicate difficulties in DNA replication
and breakage at fragile sites as a frequent mechanism to generate CNVs in somatic cells. Over-
all, large scale structural changes in the clones leading to copy changes were 4 to 10—fold
lower than the median levels of CNVs detected in cancer genomes [38] and did not indicate
any impact of sun exposure.
Genome-wide catalogs of somatic base-substitutions
To obtain accurate estimates of the somatic single nucleotide variations (SNVs) in the progeni-
tor cell that gave rise to the clonal lineages, we obtained consensus somatic mutation calls from
three independent callers: the haplotype caller from GATK [39], VarScan2 somatic mutation
caller [27], and MuTect [40]. Somatic base-substitutions in the clones represented the largest
number of genetic changes, from 581 to 12,743 (Fig 3A). SNVs were considered clonal and
somatic if they were absent in the bloodDNA and had allele frequencies between 45% and 55%
or greater than 90% (S6 Fig, S6 Table and S7 Table). These filtering criteria allowed us to
exclude mutations that are coming from germline as well as those that may have arisen in the
first cell division in culture. 102 of the SNVs identified as somatic and clonal were PCR ampli-
fied and Sanger sequenced for further validation. Of these, we were able to get amplification
and sequencing results for 87 loci containing SNVs, and all were validated as true somatic
events (S6 Table). We uncovered only one shared mutation between clones isolated from
Donor 1, from the left forearm, and two mutations common in clones isolated from the fore-
arms of Donor 2 (S7 Fig). We propose that the dearth of mutations common to clones from
the same subject is due to the high cell turnover rates in the dermis. Indeed, the area of human
skin increases only 6-fold in postnatal development to adults [41]. If turnover rate is uniform
across the body only six fibroblasts of the adult dermis would share a common ancestor from
the neonatal stage.
Fig 3. Somatic mutation load and spectra in the fibroblast clones. (A) The number of somatic mutations detected in each clone and the rate of
accumulation of mutations per year are provided. (B) The spectra of base changes in the clones. For each base change the reverse complements are
also included.
doi:10.1371/journal.pgen.1006385.g003
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Exome sequencing from bulk fibroblast cultures to 100X – 200X coverage, revealed the pres-
ence of a large number of somatic mutations identical to mutation calls in clones (264/387) (S6
Table). 90% or more of the SNVs detected in the exomes of each sample have frequencies
5%, while mutations with as little as 2% frequencies were also called (S8 Fig and S8 Table). All
samples except D2-L-F contain 1 peak with the majority of SNVs having allele frequencies
between 5–15%. In the D2-L-F bulk sample, the SNVs are distributed between 2 peaks with
allele frequencies between 5–15% and 25–50%. This distribution of allele frequencies implies
that there is 1 major clonal lineage present in this population thus contributing to high allele
frequencies of the SNVs detected, and a smaller population comprised of multiple clonal line-
ages contributing to mutations with frequencies in the range of 5 and 15%. The distribution of
allele frequencies can be explained if there are at least 10 clones present within each biopsy.
This hypothesis is corroborated by the observation that the numbers of somatic mutations
detected in the exomes of bulk cells are comparable to the expected number of mutations if
there were at least 10 clones similar to those isolated from the same biopsies (S9 Table). These
data point towards the highly heterogeneous nature of skin. Altogether, deep exome sequenc-
ing of the source bulk cultures further confirmed that the SNVs detected in the clones were
present in the skin biopsy and were not an artifact of growing the cells in culture.
Human somatic mutation rates
Based on the shortening of telomeres in the fibroblast clones we estimated that the cells under-
went a minimum of 60 to 70 post-natal cell divisions in the body prior to biopsy and clone for-
mation (seeMethods). Therefore, the maximal estimates of somatic mutation rates in clones
accounting for only the postnatal divisions are ~1x10-9 to 3x10-8/nucleotide/cell division.
Assuming that genetic changes occurred at a steady rate in the somatic cells, we can further cal-
culate the rate of mutation accumulation in skin fibroblasts to be 9–220 mutations/genome/
year (Fig 3A and S10 Table). This is close to the estimates of age-dependent accumulation of
certainmutation types in cancer genomes [5].
Mutation signatures in the clones
The overall mutation loads in fibroblasts obtained from the forearms were higher than the
fibroblasts isolated from hips of the same donors suggesting the involvement of UV in the ori-
gin of mutations in the forearms. In our samples, the most prevalent base change was C!T
(Fig 3B), which is the prevailing change in several mutagenic pathways [42]. We therefore
explored mutation spectra in clones by applying statistical analysis based on prior mechanistic
knowledge using a similar approach as previously implemented for APOBEC cytidine deami-
nase-inducedmutagenesis in human cancers (outlined in [42–44] and Methods), which
provides sufficient power to detect mutagenic patterns in individual samples. In brief, we deter-
mined if counts of mutations at a given motif, consistent with a specificmutagenic mechanism,
are statistically enriched as compared to mutation counts expected by randommutagenesis.
For samples with statistically significant enrichment we then calculate the minimum estimates
of mutation loads attributable to the mutagenic mechanism. One known pathway of C!T
mutagenesis is initiated by deamination of methylated cytosines in CpG dinucleotides [42].
Mutations at methylated CpG dinucleotides leading to C!T changes have been shown to
increase in a “clock-like” manner with age [5, 45]. Indeed, we found an enrichment of C!T
mutations at nCgmotif (shown in trinucleotide format, mutated nucleotide capitalized, n is
any nucleotide) in all clones analyzed (Fig 4A and 4B, and S11 Table). However, this load rep-
resented no more than 5% to 40% of all C!T changes, indicating that other mutational mech-
anisms are also functional in the clones.
Somatic Mutagenesis Over Human Lifetime
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UV-A exposure leads to the formation of mutagenic cyclobutane pyrimidine dimers and
pyrimidine (6–4) pyrimidone photoproducts [47, 48]. Deamination of cytosines forms uracil
leading to C!T changes in the genome and this rate is 106-fold higher for cytosines within
cyclobutane pyrimidine dimers [49] To evaluate the contribution of UV-induced mutagenesis
in the single cell-derived fibroblast clones we examined C!T changes in the 3’C present in
TpC or CpC contexts, and tandem CpC!TpT dinucleotide changes [15, 48, 50]. We observed
a higher incidence of these substitutions in most forearm samples as compared to hips in the
same donor (Fig 4A–4C and S11 Table).
Analyses of trinucleotidemotif-specificmutation signatures enable us to detect apparent
contribution of UV-mutagenesis even when there is an overlap with a mutation signature com-
monly associated with endogenous processes. Mutations at CpGmotifs leading to C!T
changes have been attributed to age-dependent mutation accumulation due to intrinsic deami-
nation of methylated cytosines. However, CpG motifs present in the yCg trinucleotide contexts
have also been shown to be efficientlymutated by UV because of higher efficiency formation of
Fig 4. Analysis of mechanistic knowledge-based mutation signatures in the genomes of skin fibroblasts. Similar analysis for the whole-genome
sequenced melanoma (SKCM) cohort (dataset from [46]) is provided for comparison. (A) Fold enrichment of nCg!nTg and UV-signature mutations
(yCn!yTn, nTt!nCt; y is either C or T, n is either A, T, G or C, in the trinucleotide context the mutated base is in capital). The black horizontal line denotes
the level of no enrichment. (B) The minimum estimates of signature-specific mutation loads for each clone. For the melanoma cohort, the median of the
minimum estimated mutation loads for each signature per genome in is shown. (C) Total CC!TT counts of tandem dinucleotide changes in each clone and
the median of the total CC!TT counts per genome in the melanoma cohort.
doi:10.1371/journal.pgen.1006385.g004
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pyrimidine dimers, which include methylated cytosine [51, 52]. In agreement with such a pre-
ferred dimer formation, enrichment and minimum estimates of mutation loads attributable to
the yCg!yTgmutation signature were higher than for rCg!yTg in most samples, suggesting
that a large fraction of yCg!yTgmutation are due to UV-induced DNA damage rather than
to spontaneous deamination of 5-methyl cytosine in 5me-CpG (nCg!nTg) mutation load
(S9A Fig). Alternatively, this could be caused by, not yet identified, influence of the nucleotide
5’ to meCpG on the rate of spontaneous deamination of meC resulting in C!Tmutations.
Since, we clearly detected a significant contribution of UV-induced mutagenesis in C!T
changes in the clones from the forearms; we further analyzed the role of UV in mutagenizing
A:T base pairs as well. UV-induced dimers can be also formed between adjacent thymines.
Consistently, in the clones derived from forearms we see increased levels of TT!CT base sub-
stitutions in the forearms as compared to hip samples from the same donor (Fig 4A and 4B
and S11 Table).
In order to support the accuracy of our mechanistic knowledge based signature analysis for
UV-induced mutations, we further analyzed published whole-genomemutation catalogues of
melanomas [46]. Melanomas are known to have a large number of UV-induced mutations and
whole genomemutation calls were available for this cancer type.We clearly see high incidence
of all three kinds of UV-signature mutations in these genomes (Fig 4A–4C and S11 Table). Simi-
lar UV-signature mutations have also been found in cutaneous squamous cell and basal cell car-
cinomas, where only exomes were sequenced ([15] and references therein). In vitro and in yeast,
bypass of UV-induced photoproducts at TT tandem bases by the translesion polymerase Polη,
predominantly leads to a change in the 3’T causing a TT!TC base substitution[53, 54]. How-
ever, in healthy skin cells, and in melanoma samples we detect an enrichment of mutations in the
5’T (Fig 4A and 4B and S11 Table), indicating differences in the mechanism underlyingUV-
induced lesion bypass in humans and model systems. One explanation for this bias towards
mutations in the 5’T could be that there is an overrepresentation of pyrimidines in the -1 position
in the nTt motif in our dataset. Formation of pyrimidine dimers at YT dinucleotides, and bypass
could lead to T!C changes, thus confounding our analyses centered on the nTt motif. There-
fore, we determined enrichment and minimummutation loads for the non-overlapping parts of
nTt motif—yTt and rTt (y is a pyrimidine, r is a purine). Interestingly, we clearly detect higher
enrichment and mutations leading to rTt!rCt changes than yTt!yCt changes (S9B Fig, S11
Table), thus supporting our conclusion that in normal human cells and in melanomas, the 5’T in
a thymine dimer is preferentially mutated and leads to T!C changes.
Mutation density correlates with replication timing and chromatin status
Mutation rates in cancers as well as in germline vary between regions of the genome that repli-
cate early or late, and that have open or closed chromatin [14, 55, 56]. This tendency for
increasedmutations in repressed chromatin was also detected in whole-genome sequenced
DNA from a single skin biopsy obtained from eyelids of healthy individuals [15]. To assess the
dependence of somatic mutagenesis on these epigenomic features we used Repli-seq data for BJ
cells (derived from normal foreskin fibroblasts) from the ENCODE project [57] and DNase I
hypersensitivity data from NHDF-Ad cells (adult dermal fibroblasts). These cell types were
selected as they were the closest in origin to the fibroblast clones analyzed in our study. Like
cancer genomes, where late replicating and heterochromatin-rich regions have more mutations
than early replicating euchromatic regions [55, 56], SNV density in the fibroblast clones, corre-
lated with replication timing and the chromatin status. This bias was more pronounced in fore-
arm samples than in the hips (Fig 5A, S10 Fig, S11 Fig and S12 Table), and was also observed
for UV-induced mutations (S12 Fig and S12 Table).
Somatic Mutagenesis Over Human Lifetime
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Transcription-associated bias for SNV density
UV-signature mutations present within transcribed regions of the genome were further classi-
fied based on whether the mutations occurred in the transcribed or non-transcribed strand. In
four out of five forearm samples and in three out of five hip samples we observedmore of these
mutations in the non-transcribed strands (Fig 5B and S13 Table), which is in accordance with
the activity of transcription-coupled repair [15, 45, 58]. Analysis of mutations of pyrimidines
that did not conform to any of UV-mutagenesis signatures did not demonstrate bias towards
the non-transcribed strand.
Discussion
Determination of somatic mutation loads accumulated in healthy individuals has been difficult
due to the underlying inaccuracies of the methods used to obtain mutation spectra in single-
cells. In this study, through establishment of single-cell clonal lineages with no re-program-
ming and with minimal propagation or manipulation post extraction from the human body,
we have determined the different types and extent of somatic genome changes that accumulate
in skin fibroblasts in two healthy individuals. Our approach allows us to accurately identify
changes that were present in a single cell in skin, and to further validate these changes
independently.
We found that each somatic cell carries at least one somatic structural variation leading to
change in copy number. Previously, genome sequencing of skin-fibroblast-derived cell lines led
to the prediction that 30% of these cells carry large scale CNVs [59]. Also, single cell analysis of
neurons from healthy individuals and a patient with hemimegalencephaly demonstrated the
presence of megabase scale somatic CNVs [60]. Our analyses reveals that somatic CNVs are
commonly present in the human genome and are likely stemming from double strand break
formation during DNA replication over fragile sites in the genome.
We demonstrate that the mutation load in healthy cells (ranging from 581 to 12,743 muta-
tions, Fig 3A) can be comparable to the mutation loads in some cancer genomes (median
~6000 mutations/cancer genome [61]) and the spectra as well as the correlation of base substi-
tution density with epigenomic features resemble many cancers. Apparent variability of muta-
tion loads between the donors precludes generalizing our mutation rate measurements to a
population-scale, nonetheless our study provides accurate estimates of the impacts of both UV
and endogenousmutational processes on the mutation loads in skin fibroblasts of healthy
human individuals. Since, the fibroblasts in the dermis of the hips would have had no or much
lower UV exposure as compared to forearms, we inferred that mutations not attributable to
UV were most likely representative of endogenousmutagenic processes in these samples. On
the contrary, mutations in forearms would carry a greater fraction of UV-induced mutations.
We note that some of the UV-like mutations might be caused by other non-UV processes, and/
or UV-induced damage may culminate into, hitherto unknown, non-UV-signature mutations.
Therefore, the conservative approach would be to count endogenousmutations in hip cells as
the total mutation loads minus minimum estimate of mutations due to UV (referred to as
Endogenous (cons.) in Table 1), and the minimum estimates UV-induced mutation rates from
Fig 5. Somatic mutation loads vary with replication timing and transcription status. (A) SNVs from both, hips and forearms are
enriched in late replicating genomic regions and heterochromatic regions of the genome. Values on the horizontal axis were obtained
by averaging values of the genomic feature into 5 equal bins. (B) UV-attributable mutations demonstrate a strand bias for the non-
transcribed strand. * denotes p-value after false discovery rate (FDR) correction for multiple hypothesis testing < 0.05, *** denotes p-
value after FDR correction < .01 (p-values are in S13 Table). There is no preference for non-transcribed strand for mutations in C and T
which do not conform to any UV-signature motif.
doi:10.1371/journal.pgen.1006385.g005
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the forearms as an assessment of mutagenesis by this environmental factor (referred to as UV-
induced (min.) in Table 1). Comparison of these two categories of mutations suggests that UV-
induced and non-UVmutation rates are highly similar in skin fibroblasts (Table 1). We also
used an alternative approach for estimating mutagenesis by endogenous damage taking all
mutations from the hips of a donor as a maximum estimate of endogenousmutagenesis
(referred to as Endogenous (max.) in Table 1) to be also compared with UV-induced (min.)
value for the same donor. This approach also leads to the same conclusion that the rate of
mutagenesis by environmental DNA damage (UV) is comparable to the endogenousmutation
rates in human skin fibroblasts. These data indicate that the mutation loads can be modulated
to a similar extent by environmental and endogenous DNA damage in somatic cells.
The mutation load per fibroblast was at least 600 substitutions (Fig 3A). In an average
human body there are approximately 1012 dermal fibroblasts [62], thus the skin as a whole
could carry ~1014 SNVs. However, based on the observed allele fractions of somatic mutations
revealed by deep exome sequencing of bulk cultured cell populations from 8 biopsies, a signifi-
cant fraction of these SNVs would be the same, and thus belong to the same clonal lineage (S8
Fig, S8 Table and S9 Table). Such a clonality of mutations could be due to a combination of
random cell death, mutation specificity, and selection, which would result in high incidence of
certain somatic changes. Recent study based on analysis of TCGA sequence data for normal tis-
sues adjacent to excised tumors did not find evidence of strong purifying selection against new
potentially deleteriousmutations [63]. In fact, another study involving deep sequencing of
genomic DNA obtained from non-cancerous human skin indicated that there is even some
level of selection for changes in certain genes implicated in carcinogenesis [15]. Interestingly,
23 out of 387 somatic mutations in exons were also present in the COSMIC database (S6
Table). We propose that similar to significantlymutated genes in cancers [61], there are genes
Table 1. Estimates of rates of accumulation of endogenous and UV-induced mutations per year.
Site UV-induced
mutation rate
per yeara
Endogenous
mutation rate per
yearb
Total mutation
rate per yearc
Source of
damage–
Approach 1d
Average rate of
mutations by
source–Approach 1
Source of
damage–
Approach 2e
Average rate of
mutations by
source–Approach 2
D1-R-H1 5 13 22 Endogenous
(cons.)
9.7 Endogenous
(max.)
14.0
D1-R-H2 2 9 11
D1-L-H 2 7 9
D1-R-F 3 12 17 UV-induced (min.) 10.3 UV-induced (min.) 10.3
D1-L-F1 17 51 86
D1-L-F2 11 36 63
D2-R-H 9 24 34 Endogenous
(cons.)
32.5 Endogenous
(max.)
57.0
D2-L-H 20 41 80
D2-R-F 54 127 220 UV-induced (min.) 46.0 UV-induced (min.) 46.0
D2-L-F 38 84 148
a UV-induced mutation rates are calculated as the sum of minimum mutation loads by the yCn!yTn, nTt!nCt and CC!TT mutation signatures, divided by
the age of the donors.
b Endogenous mutation rate per year is calculated by subtracting minimum mutation loads attributable to UV from the total mutation loads in the clones and
dividing by the age of the donors.
c Total mutation rate per year is calculated by dividing the total mutation load by the age of the donors.
d In Approach 1, average Endogenous (cons.) mutation is calculated as the average of the “Endogenous mutation rate per year” for the hip samples of each
donor. Average UV mutation rates in forearms are the average of the “UV-induced mutation rate per year” for the forearm samples of each donor.
e In Approach 2, average Endogenous (max.) mutation rate is calculated as the average of the “Total mutation rate per year” for the hip samples of each
donor and compared to the average UV mutation rates in forearms of the same donor.
doi:10.1371/journal.pgen.1006385.t001
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mutated in normal skin cells above random frequency expectations. Our work provides a plat-
form for testing this hypothesis by systematic exploration of somatic mosaicism in humans.
The somatic mutation loads in single-cell lineages provide information about an individual’s
lifetime history of mutagenic exposure and the impact of intrinsic factors on mutagenesis.
Expanding this study to more cell types and a larger population would further refine estimates
of the rates of somatic changes in human genomes. Understanding the contributions of envi-
ronmental and endogenousmutagenic processes to somatic mutation loads is fundamental in
developing preventive strategies, and in building better diagnostics and therapeutics to combat
cancers and other genetic diseases.
Materials and Methods
Sources of cells
All participants gave written informed consent for tissue donation through the Sample Collec-
tion Registry for Quality Control of Biological and Environmental Specimens and Assay Devel-
opment and Testing protocol (registered with ClinicalTrials.gov, number NCT01087307, and
approved by the NIH Institutional ReviewBoard at the National Institute of Environmental
Health Sciences (NIEHS), protocol # 10-E-0063). We obtained 4 mm diameter skin punch
biopsies from the left and right lateral forearms and hips and whole blood from two Caucasian
male donors, ages 58 and 62 (Fig 1). Areas for biopsy were identified as free of moles, hair and
previous scars. Lateral forearm was away from area that would be covered by a watch. Hip area
was under area that would be covered by shorts but away from groin. The skin was sectioned
into approximately 6 parts and the sections were allowed to adhere to a cell culture dish. Dul-
becco’s modified eagle’s medium (Gibco 11965118) supplemented with 1X non-essential
amino acids (ThermoFisher 11140–050), 10% Cosmic Calf Serum (Hyclone SH30087), 10%
AmnioMax C-100 supplement (Gibco 12-556-015) and 100μg/ml primocin (Invitrogen ant-
pm-1) and the cultures were incubated at 37°C in a 5% carbon dioxide containing incubator.
Fibroblasts were selected for their ability to grow well in culture with high cloning efficiency
(4–5%). They were identified based on their elongated shape and ability to grow adhered to the
tissue culture dishes in the presence of serum-containingmedia (S1 Fig). It took approximately
3–4 weeks for confluent fibroblast growth from the tissue fragments. The fibroblasts were har-
vested, diluted and plated to obtain single-cell derived clones. The clones were expanded in cul-
ture for, 5 to 6 additional passages (4–6 weeks), to obtain 106 cells and genomic DNA was
extracted (DNeasy Blood and Tissue kit, Qiagen). Venous blood for DNA isolation was col-
lected in five 8.5 ml PAXgene bloodDNA tubes (PreAnalytiX/Qiagen:Valencia, CA).
Whole genome/exome sequencing
We used the KAPA Hyper (KAPA Biosystems) kit for whole genome sequencing (WGS)
library preparation. Size selection of constructed libraries was performed using Pippin prep
(SAGE Science).DNA libraries were used to obtain Paired-End 100 (Rapid V2 chemistry) or
125 bp (V4 chemistry) reads fromHiSeq 2500 sequencer (Illumina). Each DNA library was
sequenced on 4 lanes to get an average coverage of 40X to 60X for whole genomes, and 100X to
200X for whole exomes (WES) (S1 Table). For whole exome (37 Mb target size) sequencing,
Nextera Rapid Capture Exome Kit (Illumina) was used to prepare the library prior to sequenc-
ing. The raw FastQ files were filtered to keep only read pairs with an average base quality score
of 20 or more and were then aligned to the reference human genome (GRCh37) using BWA-
MEM-0.7.10 [64] using the default parameters and the resulting BAM files were merged.
Duplicate reads were removed from the resulting BAM files using MarkDuplicates from Picard
Tools. The BAM files were processed according to the Genome Analysis Toolkit (GATK) best
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practices pipeline [39, 65]. The length of the genome with coverage greater than or equal to
10X was estimated using the BedTools genomeCoverageBed command [66] (S1 Table). The
final BAM files and complete lists of somatic mutation calls in WGS andWES samples have
been deposited into dbGAP approved study under accession number phs001182.v1.p1.
Detection of somatic retrotransposition and clonality estimation
The published method, scTea [67] was applied to detect insertions of retrotransposons (L1,
Alu and SVA) in ten fibroblast clones. At least 5 supporting read pairs and the score higher
than 0.6 were required. The germline non-reference insertions were filtered out using the
blood genome from the same donor. 13 raw insertion candidates were manually inspected
using the Integrative Genome Viewer, and two candidates remained as a final call set (S2
Table). The clonality of each event was estimated by calculating the ratio of discordant reads
pairs supporting the insertion (i.e., repeat-anchored mate read (RAM) counts) to the sum of
the RAM counts and the number of concordant read pairs across the insertion breakpoint (i.e.,
those supporting the non-insertion allele). The top high confidence insertion candidate found
in the clone D1-L-H (L1#1) resides in a genomic region with large tandem duplication in the
germline genome thus having an elevated sequencing depth with poor read mappability
whereas the other candidate found in the D2-R-F clone (L1#2) resides in a genomic region
with the expected depth and goodmappability. To more accurately estimate the clonality of
the event like L1#1, we adjusted the number of concordant read pairs by the relative sequencing
depth to the genomic average depth and recalculated the allele frequencywith an assumption
that the insertion allele exists in only one of the many duplicated genomic regions. This copy
number adjusted clonality provides us an upper bound of the event clonality (S2 Fig).
Annotating copy number variations and structural variations
Large-scale clonal copy number changes in the clones were detected using the VarScan2 copy
number tool on pileup files generated using Samtools mpileup command [27, 68]. This tool
detects changes in coverage in the DNA samples from the clones as compared to their corre-
sponding blood sample. Circular binary segmentation was applied to the output using the
DNAcopy package in R [28, 69, 70] (S3 Fig, S4 Fig and S3 Table).
Somatic structural changes in the form of large deletions, inversions, duplications and trans-
locations were detected using the software DELLY [29] using the default settings (S3 Fig, S4 Fig
and S4 Table). Alignments of bloodDNA reads were used as the “matched normal” to detect
clone-specific somatic events. Centromeric and telomeric regions were excluded from the anal-
yses. For each sample a structural variation event was called if> 30% of the reads in the region
supported the call and there were 0 reads supporting the event in the corresponding blood
sample (S4 Table). The structural variations were further validated by PCR as describedbelow
and any variants detected in bloodDNA were discarded (S5 Fig).
Somatic mutation calling and annotation
Single nucleotide variations (SNVs) for WGS samples were analyzed using three mutation call-
ing tools, the haplotype caller from GATK [39], VarScan2 somatic mutation caller fromWash-
ington University, St. Louis [27], and MuTect from the Broad Institute of Harvard and MIT
[40]. SNVs were called somatic if they were present in the clone and were not detected in the
blood of the same donor. VarScan2 and MuTect were run using the alignment files from whole
blood from a donor as the “normal” for each clone isolated from this donor. The SNV calls
were limited to regions with a minimum of 10X coverage with at least 3 reads supporting the
mutation call. The list of SNVs generated were filtered to remove calls that match known
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dbSNPs (version 138) and calls that fall within known simple repeat regions (UCSCGenome
Browser, hg19 build). The consensus between the 3 callers was taken and filtered further for
allele frequency to provide the final mutation calls. Calls with an allele frequency between 45%
and 55% were denoted as heterozygous mutations, and those with an allele frequency> 90%
were denoted as homozygous mutations. Homozygous SNVs may arise in the genome as muta-
tions in genomic regions with copy number = 1 (e.g. X chromosome or autosome region het-
erozygous for a deletion)or by loss of heterozygosity following a mutation in the autosomes.
Mutations with allele frequencies not falling within these criteria were discarded. Since, the
samples sequencedwere clonal in nature, 61% to 73% of the SNVs called by the three mutation
callers were contained within these allele frequencies (S6 Fig, S6 Table and S7 Table).
VarScan2 was also used to annotate loss of heterozygosity (LOH) events in the clones as
compared to their respective blood samples. The LOH events in the clones were expected to
have an allele frequency> 90% and between 45% and 55% in the corresponding blood samples
(S5 Table).
To detect shared SNVs between 2 or more samples, the SNV calls by MuTect were com-
pared for all samples from the 2 donors, respectively. Analyses of allele frequencies for muta-
tion calls by all 3 callers demonstrated that MuTect detects the highest fraction of somatic
SNVs. The resulting SNVs were filtered by allele frequency such that calls between 45% and
55% or alleles with frequency> 90% in either of the shared samples were further validated as
describedbelow. Only 1 SNV was confirmed to be present in both clones from the left forearm
in donor2, and 2 SNVs were validated to be identical between the clones from the left and right
forearms of Donor2 (S7 Fig).
Mutations were annotated for their presence within exons and for their functional conse-
quences and potential roles in cancers, using the software Annovar [71] and CRAVAT [72] (S6
Table).
Exome mutation calling
The bulk fibroblasts that outgrew from the initial biopsies from all 4 sites (forearms and hips)
for the 2 donors were used for deep sequencing of the exome with approximately 100-200X
coverage (S1 Table) and aligned to the human genome as described above. MuTect was used to
call somatic SNVs in these samples. A large fraction (264/387) of the SNVs from the bulk cells
were found to be identical to the SNVs detected by the three mutations callers in exomes of the
respective clones (S6 Table), thus further corroborating the SNV calls in the clones.
The bulk cells derived from the biopsy from the left forearm of donor 2 showed a bimodal
distribution of variant allele frequencies with the 2 peaks at ~5–10% and ~35–45%. 79 of the 83
SNVs present in the exons of D2-L-F (left forearm, donor 2) were present in the bulk sample
for the left forearm. 49 of these SNVs had allele frequencies 40% (S8 Fig, S6 Table and S8
Table). These observations indicate that the biopsy segment for the left forearm for donor 2
primarily contained one clonal lineage from which the clone D2-L-F was derived. In the 7
other bulk samples, the majority of the SNVs called were between 5 and 15% (S8 Fig and S8
Table). These allele frequencies can be explained if each biopsy segment contained a minimum
of 10 clonal lineages. Based on this, we estimated the minimum expected exonic mutation
loads in a given biopsy segment by multiplying the number of mutations detected in the exome
of the clones derived from the bulk cells by 10 (S9 Table).
Estimation of mutation rate per cell division and per genome per year
The average length of the telomeric repeats was estimated using TelSeq [73]. In newborns,
the average length of the telomere restriction fragments (TRFs) has been estimated to be
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approximately 11 kb [74, 75]. TRFs have been shown to contain 1 kb DNA between the restric-
tion site and telomeric repeats. In order to compare the telomere lengths in our samples to
newborns,we therefore added 1 kb to the lengths estimated by TelSeq. Fibroblasts have been
shown to lose 50–100 bp of the telomeres every generation [75]. Since, each clone rose from a
single cell with at least 20 cell generations, we can assess that telomeres in the progenitor cell
were 2 kb longer. This implies that the fibroblast cells that gave rise to the clones have 4–5 kb
TRFs. Based on this we can calculate that the cells underwent a minimum of 60 to 70 divisions
since the individuals were born. Since the diploid human genome is 6 x 109 nucleotides; we cal-
culate the mutation rate per nucleotide in the genome per cell division as:
Rateper nt;per cell division ¼
Mutation load
Cell divisions diploid genome ðntÞ
Because the number of prenatal cell divisions is unknown, this calculation represents the
maximum estimate of the rate. Therefore, we also calculatedmutation rate per genome per
year as another characteristics of mutation accumulation (S10 Table).
Validation of somatic mutation calls, LOH events and structural variants
Primers to amplify regions containing somatic mutations and LOH events were designed using
PrimerBlast such that approximately 500 to 1500 bp region spanning the mutated base would
be amplified [76]. 6 to 10 mutations in the exons of each clone were chosen for amplification
and Sanger sequencing. The corresponding bloodDNA was also analyzed to ascertainwhether
the mutations annotated as somatic were present in the blood (germline). 102 SNVs with
potential functional consequences were chosen for validation, of these, 87 SNVs were validated
as somatic. We were unable to PCR amplify and get high quality Sanger sequencing results for
the remaining SNVs due to difficulty obtaining primers unique to the region being amplified.
None of the somatic events were identified as germline (mutations in both clone and blood)
(S6 Table).
LOH events that were either present in protein coding regions, or were in regions with
CNVs, were taken for validation by PCR and Sanger sequencing.Only 10 such events were val-
idated due to constraints with the amount of DNA available and difficulties in obtaining prim-
ers specific to the genomic regions. The LOH event was considered somatic if it was identified
as a heterozygous allele in bloodDNA and as a homozygous mutant in the clone (S5 Table).
Structural variants were validated by PCR using primers flanking the novel junction formed
and Sanger sequencing the PCR product. The structural change was considered somatic if it
was detected in the clone and not detected in the bloodDNA (S5 Fig and S4 Table). The plots
depicting all somatic changes in the clones were generated using RCircos [77].
Calculating enrichment and mutation load for mechanistic knowledge-
based mutation signature analyses.
The enrichment of UV-induced mutation signatures and mutation load in the clones were cal-
culated similar to [43, 44] We use the termmutation signature in reference to the characteris-
tics of a given mutation including the mutated residue, the altered base and the nucleotides
that surround the residue that occurmore frequently than expectedwith randommutations in
genomic DNA. The signatures analyzed in this paper are listed in Table 2.
For UV-signatures, C!T changes in the context of the yCn motif where n is any base and y
is pyrimidine (T or C), and T!C changes in the 5’ T in the context of the nTt motif, were ana-
lyzed. Example of the calculation for enrichment of mutations within the nTt motif is pre-
sented below where, the context is derived from 41-nucleotides region containing the mutated
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residue in the center.
EnrichmentðnTt!nCtÞ ¼
mutationsðnTt!nCtÞ  contextðtÞ
mutations ðT!CÞ  contextðnTtÞ
For each motif, the reverse complement was also used in the calculations. The use of nucleo-
tide context immediately surrounding the mutation rather than the whole-genome helps to
account for localized preference of mutagenesis stemming from small range scanning by muta-
genic enzymes such as APOBEC, or the preference of lesion occurrence, lesion repair as well as
other factors including epigenomic features influencingmutagenesis within localized genomic
regions [78, 79]. These calculations do not exclude any specific genomic region, but rather use
the area in each sample, where the mutations actually happened. With large numbers of muta-
tions this approach gives results similar to calculations using whole-genome context [43].
To statistically determine the over-representation of the UV-signature mutations a one-
sided Fisher’s exact test was performed. The ratio of the number of C! T (for yCn and nCg)
or T!C (for nTt) changes that occurredwithin or out of their respectivemotifs were com-
pared to the ratio of C or T bases present within or out of the motifs above. To correct P-values
for multiple testing the Benjamini-Hochbergmethod was used.
The minimum estimate of the number of mutations attributable to UV for both nCy and
nTt motifs were calculated only for samples with enrichment> 1 also having corrected q-value
for enrichment< 0.05. For samples with enrichment< 1 and for samples with enrichment q-
value> 0.05 the minimum estimate of mutation load was assigned the value = 0. For example,
minimummutation load for nTt!nCt was calculated as
MutLoadðnTt!nCtÞ ¼
mutationsðnTt!nCtÞ  ðEnrichmentðnTt!nCtÞ   1Þ
EnrichmentðnTt!nCtÞ
Mutagenesis in CpG leading to nCg! nTg changes was evaluated in a similar way (Fig 4A
and 4B and S11 Table).
Total tandem CC!TTdinucleotide changes were calculated for each sample (Fig 4C and
S11 Table). This mutation signature is known to be unique to UV and the probability of ran-
dom CC!TT changes not by UV is extremely low [50].
In order to assess the contributions of the -1 nucleotide in the nCg and nTt mutation
motifs, we also evaluated rCg!rTg, yCg!yTg, rTt!rCt and yTt!yCt mutation signatures
as described above.
Table 2. Mutation signatures analyzed in this study.
Signature motif (abbreviated) Signature motif (detailed) Base substitution in a motif (a.k.a. mutation signature)
nCg 5’ [a|t|g|c]C[g] 3’ nCg!nTg
rCg 5’ [a|g]C[g] 3’ rCg!rTg
yCg 5’ [t|c]C[g] 3’ yCg!yTg
yCn 5’ [t|c]C[a|t|g|c] 3’ yCn!yTn
nTt 5’ [a|t|g|c]T[t] 3’ nTt!nCt
rTt 5’ [a|g]T[t] 3’ rTt!rCt
yTt 5’ [t|c]T[t] 3’ yTt!yCt
The mutated residue is capitalized in the center of the motif. In the detailed signature motif, possible nucleotides for a position are show in brackets
separated by |.
doi:10.1371/journal.pgen.1006385.t002
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Correlation of somatic mutation density with replication timing,
chromatin status and transcription
Replication timing for each 1Mb window of the genome was determined by taking the average
of the wavelet-smoothed signal. The average replication timing was binned into 5 equal bins
and the mean mutation density per Mb was calculated for each bin (Fig 5A, S10 Fig and S12
Table). The total number of DNase I hypersensitive peaks were calculated across 1Mb windows
in the human genome. The data was binned into 5 equal bins and mean mutation density was
calculated for each bin. BEDtools suite was used to map peaks to 1Mb intervals (Fig 5A, S11
Fig and S12 Table). Variation of UV-induced mutation density with replication timing and
DNaseI hypersensitivity levels was also determined for yCn!yTn, nTt!nCt and CC!TT
mutations (S12 Fig and S12 Table).
To statistically determine the over-representation of mutations in pyrimidines due to UV in
the non-transcribed strand of genes, the number of C!T and T!Cmutations in the yCn and
nTt contexts and CC!TTmutations were determined for both strands of transcribed genes,
and a one sided binomial test was performed expectation that more mutations are present on
the non-transcribed strand. To correct P-values for multiple testing the Benjamini-Hochberg
method was used. Similar comparison was done for mutations in pyrimidines not conforming
to UV-signatures (Fig 5B and S13 Table).
Code availability
The R-code for analysis of all mutation signatures will be provided on request.
Supporting Information
S1 Fig. Representative image of the fibroblasts isolated from human dermis in this study.
(TIF)
S2 Fig. Clonality of somatic L1 insertions.Estimated allele frequencies of the two somatic L1
insertions (L1#1 in D1-L-H and L1#2 in D2-R-F clones) were shown in blue and yellow lines,
respectively. The histograms of allele frequencies of germline non-reference L1 insertions that
were detected from the blood genomes of the two donors and also reported in the literature were
shown with (left) and without (right) copy number adjustment. The twomajor peaks in the his-
tograms represent heterozygous and homozygous germline insertions. The heterozygous germ-
line insertions show slightly higher allele frequencies than 0.5 because some discordant read pairs
were counted twice due to additionally derived read pairs from the same DNA fragments. The
two somatic L1 insertions were not clonal and likely arose during propagation of cells in culture.
(TIF)
S3 Fig. Circos plots depicting all the genetic changes detected in the clones isolated from
Donor1. The tracks represent the following features–Track1 (innermost track) = rearrange-
ments detected by Delly (green = deletions, blue = inversions, black = duplications, red = trans-
locations); track2 = deletions as detected by read-depth analyses; track3 = genomic regions
with 3N copy number as detected by read-depth analyses; track4 = LOH events; track 5 = SNV
positions, red dots = homozygous alleles, black dots = heterozygous alleles and
track6 = chromosome ideograms.
(TIF)
S4 Fig. Circos plots representing genetic changes in clones fromDonor2. The tracks, as
numbered from the innermost track, represent: track1 = all rearrangements (green = deletions,
blue = inversions, black = duplications, red = translocations); track 2 and track 3 = genomic
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regions with deletions and amplifications as detected by read-depth analyses, respectively;
track 4 = genomic positions for LOH events; track 5 = SNVs (red = homozygous,
black = heterozygous); track6 = chromosome ideograms.
(TIF)
S5 Fig. Example of validation of somatic structural variants in the clones.The newDNA junc-
tion formedwas amplified. The structural change (yellow arrow) is present in the clone (C) and
absent in blood (B) DNA. If the somatic change is a heterozygous deletion, and is< ~2 kb in
length, the full length product can also be amplified (blue arrow) and is expected to be present in
both blood and clone DNA. 1 = D1-L-F1 deletion chr5:125315996–125316120; 2 = D1-L-F1
deletion chr18:34125127–34241348; 3 = D1-R-F deletion chr2:24964091–24965103.
(TIF)
S6 Fig. Distribution of allele frequencies of the consensus SNVs calledby the threemuta-
tion callers.The X-axis denotes allele frequencies in 5% increments. The Y-axis represents the
percentage of SNVs in each sample with the given allele frequencies. The percentage of muta-
tions with allele frequencies between 45% and 55% and with frequencies> 90%, respectively, is
provided.
(TIF)
S7 Fig. Validation of shared SNVs between 2 clones.The mutation identical to the 2 clones
from the left forearm of Donor1 (chr1:152671788 C!T), and the two mutations present in
both the left and right forearms of Donor2 (chr12:433518 C!T and chr14:99090650 A!G)
were PCR amplified and Sanger sequenced. In DNA isolated from whole blood, only one peak
corresponding to the reference allele is detected. On the other hand, we can detect 2 peaks for
the heterozygous reference and mutated alleles in both clones where the mutation is present.
(TIF)
S8 Fig. Distribution of allele frequencies of the SNVs detected in the bulk exomes.X-axis
denotes allele frequency in increments of 5%, and the Y-axis represents the number of SNVs at
the given allele frequency.
(TIF)
S9 Fig. Analysis of the nucleotide preference at the +1 position in the nCg!nTg and
nTt!nCt mutation signatures. (A) Comparison of the fold enrichment and minimummuta-
tion loads of the rCg!rTg (blue bars) and yCg!yTg (yellow bars) mutation signatures (r is
any purine and y is any pyrimidine). (B) Comparison of the fold enrichment and minimum
mutation loads of the rTt!rCt (pink bars) and yTt!yCt (orange bars) mutation signatures.
Black line depicts enrichment = 1.
(TIF)
S10 Fig. Correlation of mutation density from all clones with replication timing. The bins
on the X-axis denote the wavelet-smoothed signal for replication timing per 1Mb genome win-
dow divided into 5 equal bins. All samples have positive slopes indicating that mutation density
increases in later replicating regions.
(TIF)
S11 Fig. Correlation of mutation density in all clones with DNase I hypersensitivity. The
bins on the X axis were obtained by calculating the number of DNase I hypersensitive sites per
1 Mb genome and dividing them into 5 bins. Almost all samples demonstrate higher mutation
density in regions of the genome with closed chromatin as compared to open chromatin.
(TIF)
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S12 Fig. Correlation of UV-inducedmutation density from forearm samples with replica-
tion timing and DNase I hypersensitivity. The average mutation density in each bin for all
forearm samples is plotted. The bins on the X-axis were obtained by dividing wavelet-
smoothed signal for replication timing and total number of DNase I hypersensitive peaks, per
1Mb genome window, into 5 equal bins. Increasing bin values denote later replication timing,
and higher heterochromatin levels (transition from open to closed chromatin).
(TIF)
S1 Table. Coverage statistics for clonesWGS and bulk samplesWES.
(XLSX)
S2 Table. L1 retrotransposition events in clones.
(XLSX)
S3 Table. Copy number changes detected in clones.
(XLSX)
S4 Table. Somatic structural variants detected in the clones.
(XLSX)
S5 Table. Loss of heterozygosity of SNVs detected in the fibroblasts.
(XLSX)
S6 Table. List of somatic SNVs present in the exons of the fibroblast clones analyzed.
(XLSX)
S7 Table. Distribution of allele frequencies for the consensus SNVs calledby the triple cal-
ler.
(XLSX)
S8 Table. Distribution of allele frequencies in the exomes of the bulk samples sequenced.
(XLSX)
S9 Table. Comparison of the observednumber of SNVs detected in the bulk cells with the
expectednumber from the number of changes detected in the clones.
(XLSX)
S10 Table. Somatic mutation rates in all clones.
(XLSX)
S11 Table. Motif-specificmutation enrichment andminimummutation loads.
(XLSX)
S12 Table. Distribution of mutation load with replication timing and DnaseI hypersensi-
tivity levels in the genome.
(XLSX)
S13 Table. Distribution of UV-induced and other mutations on the non-transcribedand
transcribedstrands of transcribedregions.
(XLSX)
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